USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma

Colon adenocarcinoma (COAD) is one of the diseases with the highest morbidity and mortality in the world. At present, immunotherapy has become a valuable method for the treatment of COAD. Tumor mutational burden (TMB) is considered to be the most common biomarker for predicting immunotherapy. Accord...

Full description

Bibliographic Details
Main Authors: Yuanyuan Sun, Long Li, Wenchao Yao, Xuxu Liu, Yang Yang, Biao Ma, Dongbo Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Genetics
Subjects:
colon adenocarcinoma
USH2A
tumor mutation burden
immunotherapy response
bioinformatics analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.762160/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2021.762160/full

Similar Items